Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Young adult males who cannot produce or respond to estrogen (E) are osteopenic, suggesting that E may regulate bone turnover in men, as well as in women. Both bioavailable E and testosterone (T) decrease substantially in aging men, but it is unclear which deficiency is the more important factor contributing to the increased bone resorption and impaired bone formation that leads to their bone loss. Thus, we addressed this issue directly by eliminating endogenous T and E production in 59 elderly men (mean age 68 years), studying them first under conditions of physiologic T and E replacement and then assessing the impact on bone turnover of withdrawing both T and E, withdrawing only T, or only E, or continuing both. Bone resorption markers increased significantly in the absence of both hormones and were unchanged in men receiving both hormones. By two-factor ANOVA, E played the major role in preventing the increase in the bone resorption markers, whereas T had no significant effect. By contrast, serum osteocalcin, a bone formation marker, decreased in the absence of both hormones, and both E and T maintained osteocalcin levels. We conclude that in aging men, E is the dominant sex steroid regulating bone resorption, whereas both E and T are important in maintaining bone formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hormones are known to affect bone metabolism, but bone resorption is primarily controlled by estrogen in both sexes (Clarke & Khosla, 2010; Falahati‐Nini et al., 2000; Khosla, Melton, & Riggs, 2001).”
From Facial aging trajectories: A common shape pattern in male and female faces is disrupted after menopause (2019) · cites this paper as Falahati‐Nini et al., 2000
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“estrogen has a greater effect than androgen in inhibiting bone resorption in men”
From Pathogenesis of osteoporosis: concepts, conflicts, and prospects (2005) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“testosterone has a direct effect on bone through the androgen receptors present in osteoblasts that enhance bone proliferation [46–50], or it has an indirect effect through the aromatization changes to estrogen [51].”
From The Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms (2018) · cites this paper as [51]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“To date, eight males with aromatase deficiency have been described: seven adults [17-23] and one newborn [24].”
From Aromatase inhibitors in men: effects and therapeutic options (2011) · cites this paper as [24]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In postmenopausal women, facial aging was best predicted by the years since last menstruation and mainly attributable to bone resorption in the mandible.”
From Facial aging trajectories: A common shape pattern in male and female faces is disrupted after menopause (2019) · cites this paper as Falahati‐Nini et al., 2000
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arky, R. A. (1994) · Cited by 2,632
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
Smith, E. P., Boyd, J., Frank, G. R., Takahashi, H., Cohen, R. M., Specker, B., Williams, T. C., Lubahn, D. B., & Korach, K. S. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410203311604 · Cited by 2,471
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530621 · Cited by 1,416
Effect of testosterone and estradiol in a man with aromatase deficiency
Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K. S., & Simpson, E. R. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370204 · Cited by 1,151
Riggs, B. L., Khosla, S., & Melton, L. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.763 · Cited by 1,143
Self-citationEstrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741
Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency
Bilezikian, J. P., Morishima, A., Bell, J., & Grumbach, M. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390905 · Cited by 625
Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study
Greendale, G. A., Edelstein, S., & Barrett-Connor, E. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.11.1833 · Cited by 553
Research works printed but not linked: 3
- The GLM procedure. 1990. In SAS/STAT user's guide . Sixth edition. SAS Institute Inc. Cary, North Carolina, USA. 891-996.
- Weinstein, R., et al. 1999. Like estrogen, androgens exert potent and direct anti-apoptotic effects on osteoblasts and osteocytes in vivo and in vitro. J. Bone Miner. Res. 14 (Suppl. 1):S451. (Abstr.)
- Taxel, P., and Raisz, L.G. 1997. The effect of estrogen therapy on older men with low bone mass. J. Bone Miner. Res. 12 (Suppl. 1):S353. (Abstr.)
Cited by
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
“: J Clin Invest 106:1553– 1560, 2000 (43).”
BackgroundInfluentialSelf-citationManolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
“tion of aromatase inhibitors (8); and 3) cross-sectional”
BackgroundThe Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Khosla, S., Oursler, M. J., & Monroe, D. G. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.03.008 · Cited by 943
“(5) who used an experimental design in which sex steroid production was suppressed in adult men by a combination of a GnRH agonist and an aromatase inhibitor, followed by selective replacement of either estrogen or testosterone, both, or neither, by placing the men on the respective patches.”
Self-citationKhosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Self-citationChanges in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Pathogenesis of bone fragility in women and men
Seeman, E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08706-8 · Cited by 909
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Eastell, R., O'Neill, T. W., Hofbauer, L. C., Langdahl, B., Reid, I. R., Gold, D. T., & Cummings, S. R. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.69 · Cited by 827
Self-citationGonadal Steroids and Body Composition, Strength, and Sexual Function in Men
Finkelstein, J. S., Lee, H., Burnett-Bowie, S.-A. M., Pallais, J. C., Yu, E. W., Borges, L. F., Jones, B. F., Barry, C. V., Wulczyn, K. E., Thomas, B. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1206168 · Cited by 782
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
“(397) first studied elderly men under conditions of”
Gender Disparities in Osteoporosis
Alswat, K. A. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2970w · Cited by 596
“Estrogen deficiency plays an important role in osteoporosis development for both genders, and it is more pronounced for women and at younger (menopausal) ages compared with men [16, 17].”
BackgroundOsteoporosis in Men: An Endocrine Society Clinical Practice Guideline
Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3045 · Cited by 611
“Controlled physiological studies in which androgens, estrogens, or both are selectively suppressed have demonstrated thatbothandrogensandestrogensare important regulators of bone turnover in adult men (41, 44).”
BackgroundSelf-citationA comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
“ADT administration by orchiectomy (surgical removal of the testes) or by luteinizing hormone releasing hormone injections suppresses the production of testosterone which is necessary to maintain bone mineralization.(219,220) Radiation treatment for prostate cancer also leads to bone injury through a fall in blood flow…”
BackgroundThe role of estrogen and androgen receptors in bone health and disease
Manolagas, S. C., O'Brien, C. A., & Almeida, M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.179 · Cited by 574
Aging and bone loss: new insights for the clinician
Demontiero, O., Vidal, C., & Duque, G. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x11430858 · Cited by 559
“Further studies looking at differential effects between estrogen and testosterone confirmed that estrogen deficiency was more important than testosterone deficiency in causation of bone loss in aging men [Falahati-Nini et al. 2000; Leder et al. 2003] and that the effects of estrogen on bone were independent of FSH [Sa…”
BackgroundPhysiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement
Siddiqui, J. A., & Partridge, N. C. (2016) · Physiology · doi:10.1152/physiol.00061.2014 · Cited by 534
“However, some part of the bone loss is due to reduced levels of estrogen, which is derived from aromatization of testosterone (41).”
BackgroundChemistry and Structural Biology of Androgen Receptor
Gao, W., Bohl, C. E., & Dalton, J. T. (2005) · Chemical Reviews · doi:10.1021/cr020456u · Cited by 528
Khosla, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3555 · Cited by 522
Self-citationAndropause: clinical implications of the decline in serum testosterone levels with aging in men
Matsumoto, A. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.2.m76 · Cited by 490
“The specific roles of T and E2 in regulating bone turnover were investigated recently in older men with T and E2 deficiency (induced by a GnRH agonist plus an aromatase inhibitor) treated with either physiological T or E2 replacement (334).”
BackgroundAmory, J. K., Watts, N. B., Easley, K. A., Sutton, P. R., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031110 · Cited by 475
“This “antiresorptive” effect of T also might be mediated by E2 (29) and is a main mechanism by which E2 is thought to increase BMD in postmenopausal women (30).”
BackgroundCooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017) · Physiological Reviews · doi:10.1152/physrev.00018.2016 · Cited by 466
“When combined, T and E2 were more effective in maintaining normal baseline bone remodeling than either alone (198).”
BackgroundEndocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Bone Loss after Initiation of Androgen Deprivation Therapy in Patients with Prostate Cancer
Greenspan, S. L., Coates, P., Sereika, S. M., Nelson, J. B., Trump, D. L., & Resnick, N. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0183 · Cited by 411
Mechanisms of sex steroid effects on bone
Syed, F., & Khosla, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.097 · Cited by 380
Self-citationRiggs, B. L., & Parfitt, A. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041114 · Cited by 380
“Thus, the only currently available drug that is clearly anabolic is teriparatide [PTH(1-34)] by daily injection, although a similar regimen using full-length parathyroid hormone [PTH(134)] may soon become clinically available.”
BackgroundInfluentialSelf-citationPathophysiology of Age-Related Bone Loss and Osteoporosis
Khosla, S., & Riggs, B. L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.07.009 · Cited by 376
“To address this issue, Falahati-Nini and colleagues [62] performed a direct interventional study to distinguish between the relative contributions of estrogen versus testosterone in regulating bone Table 2 Spearman correlation coefficients relating rates of change in bone mineral density at the radius and ulna to seru…”
BackgroundSelf-citationAndrogen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
“Although the importance of aromatization of T to estrogens as a mechanism underlying the effects of T on bone in men is clear (23, 53), transdermal T (300 g/d) does not result in increases in serum estradiol levels in postmenopausal women.”
Snyder, P. J., Kopperdahl, D. L., Stephens-Shields, A. J., Ellenberg, S. S., Cauley, J. A., Ensrud, K. E., Lewis, C. E., Barrett-Connor, E., Schwartz, A. V., Lee, D. C., et al. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9539 · Cited by 363
The physiology of endocrine systems with ageing
van den Beld, A. W., Kaufman, J.-M., Zillikens, M. C., Lamberts, S. W. J., Egan, J. M., & van der Lely, A. J. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30026-3 · Cited by 349
Maffei, L., Murata, Y., Rochira, V., Tubert, G., Aranda, C., Vazquez, M., Clyne, C. D., Davis, S., Simpson, E. R., & Carani, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030313 · Cited by 342
Khosla, S., Melton, L. J., & Riggs, B. L. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.262 · Cited by 305
“Moreover, short-term interventional studies in which men are made hypogonadal and are selectively replaced either with estrogen or testosterone have demonstrated the importance of estrogen in regulating both bone formation and bone resorption in adult men.((30,31))”
BackgroundSelf-citationRegulation of Bone Metabolism by Sex Steroids
Khosla, S., & Monroe, D. G. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031211 · Cited by 323
“(From Falahati-Nini et al. 2000; adapted, with permission, from the American Society for Clinical Investigation # 2000.)”
BackgroundMethodInfluentialSelf-citationSex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
“Still, T was suggested to be independently related to indices of bone formation and resorption in the intervention studies described above (276, 404, 405).”
BackgroundResultEffect of GH/IGF-1 on Bone Metabolism and Osteoporsosis
Locatelli, V., & Bianchi, V. E. (2014) · International Journal of Endocrinology · doi:10.1155/2014/235060 · Cited by 307
“E deficiency is highly correlated with bone resorption and has a major role in regulating bone resorption in men [101].”
Estrogen and the Male Skeleton
Khosla, S., Melton, L. J., & Riggs, B. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8417 · Cited by 308
A concise review of testosterone and bone health
Mohamad, N. V., Soelaiman, I.-N., & Chin, K.-Y. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s115472 · Cited by 292
The Pathophysiology and Treatment of Osteoporosis
Drake, M. T., Clarke, B. L., & Lewiecki, E. M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.06.006 · Cited by 290
Differential Effects of Androgens and Estrogens on Bone Turnover in Normal Men
Leder, B. Z., LeBlanc, K. M., Schoenfeld, D. A., Eastell, R., & Finkelstein, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021036 · Cited by 283
“(13) may not have been in a steady state at the time the individual hormonal manipulations were initiated because of supraphysiological increases in gonadal steroids that occur during the initial agonist phase of GnRH analog therapy (14).”
BackgroundSelf-citationOlder Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures
Mellström, D., Vandenput, L., Mallmin, H., Holmberg, A. H., Lorentzon, M., Odén, A., Johansson, H., Orwoll, E. S., Labrie, F., Karlsson, M. K., et al. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080518 · Cited by 279
“,((28)) using E2 or T treatment in aging men with eliminated endogenous E2 and T, it was shown that E2 is the dominant sex steroid inhibiting bone resorption, whereas both E2 and T are important in maintaining bone formation.”
Tracz, M. J., Sideras, K., Boloña, E. R., Haddad, R. M., Kennedy, C. C., Uraga, M. V., Caples, S. M., Erwin, P. J., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0036 · Cited by 275
“Bone mineral density is a surrogate marker that seems to capture the bone fracture prevention effects of estrogen therapy in women; most of this effect appears mediated by testosterone (14).”
BackgroundThe effects of smoking on bone metabolism
Yoon, V., Maalouf, N. M., & Sakhaee, K. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1940-y · Cited by 268
“The effects of estrogen deficiency in the pathogenesis of osteoporosis have been known for years in postmenopausal women but also in men with low estradiol levels [82, 83].”
BackgroundCathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
Drake, M. T., Clarke, B. L., Oursler, M. J., & Khosla, S. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1114 · Cited by 266
Self-citationRural Industries Research and Development Corporation
Griffith, R., Ryan, P., Mitchell, M. S., Walkerden, G., Robinson, S., Brown, V. A., & Walker, B. (2011) · Cited by 265
Clarke, B. L., & Khosla, S. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.02.014 · Cited by 221
Self-citationSmith, M. R., Fallon, M. A., Lee, H., & Finkelstein, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032058 · Cited by 248
“Estrogens contribute to the regulation of both bone formation and bone resorption in men (15, 16).”
BackgroundOsteoporosis in Men: A Review of an Underestimated Bone Condition
Rinonapoli, G., Ruggiero, C., Meccariello, L., Bisaccia, M., Ceccarini, P., & Caraffa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042105 · Cited by 245
Charatcharoenwitthaya, N., Khosla, S., Atkinson, E. J., McCready, L. K., & Riggs, B. L. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070207 · Cited by 235
Self-citationLongitudinal Association between Sex Hormone Levels, Bone Loss, and Bone Turnover in Elderly Men
Gennari, L., Merlotti, D., Martini, G., Gonnelli, S., Franci, B., Campagna, S., Lucani, B., Dal Canto, N., Valenti, R., Gennari, C., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030736 · Cited by 235
Regulation of circulating sclerostin levels by sex steroids in women and in men
Mödder, U. I., Clowes, J. A., Hoey, K., Peterson, J. M., McCready, L., Oursler, M. J., Riggs, B. L., & Khosla, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.128 · Cited by 229
“For study B, as described previously,((8,10)) the primary method of analysis to dissect out effects of E versus T on the various parameters took advantage of the factorial design.”
BackgroundMethodInfluentialSelf-citationImpact of estrogens in males and androgens in females
Hammes, S. R., & Levin, E. R. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125755 · Cited by 225
“In elderly hypogonadal men with elevated markers of bone resorption characteristic of enhanced osteoclast activity, testosterone replacement is minimally effective in suppressing these markers (12).”
BackgroundClarke, B. L., & Khosla, S. (2009) · Steroids · doi:10.1016/j.steroids.2008.10.003 · Cited by 223
“[6] Falahati-Nini A, Riggs BL, Atkinson EJ, O’Fallon WM, Eastell R, Khosla S.”
BackgroundSelf-citationTestosterone replacement therapy: current trends and future directions
Nieschlag, E., Behre, H. M., Bouchard, P., Corrales, J. J., Jones, T. H., Stalla, G. K., Webb, S. M., & Wu, F. C. W. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh035 · Cited by 224
Invited Review: Pathogenesis of osteoporosis
Seeman, E. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00564.2003 · Cited by 222
“Nevertheless, increases in BMD in young men and declines in older men are related to circulating free estrogen, not testosterone (18, 48, 67).”
BackgroundPathogenesis of Age-Related Bone Loss in Humans
Khosla, S. (2013) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls163 · Cited by 222
“In order to address this issue, we (52) performed a direct interventional study to distinguish between the relative at U niersity of an D igo C oley L irary on Sptem er (3)0, 2014 htt://biom edgerontolxfordjournals.”
BackgroundSelf-citationExpanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)
Gao, W., & Dalton, J. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.01.003 · Cited by 215
“By contrast, estrogen has a major role in regulating metabolic processes [25,26], mood and cognition [27], cardiovascular disease [28,29], sexual function including libido [30], and bone turnover in men [31,32].”
BackgroundVilaca, T., Eastell, R., & Schini, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00012-2 · Cited by 210
Self-citationThe Effect of Tobacco Smoking on Bone Mass: An Overview of Pathophysiologic Mechanisms
Al-Bashaireh, A. M., Haddad, L. G., Weaver, M., Chengguo, X., Kelly, D. L., & Yoon, S. (2018) · Journal of Osteoporosis · doi:10.1155/2018/1206235 · Cited by 209
“Estrogen acts via suppression of bone resorption [43–45]; testosterone has a direct effect on bone through the androgen receptors present in osteoblasts that enhance bone proliferation [46–50], or it has an indirect effect through the aromatization changes to estrogen [51].”
BackgroundBone Aging, Cellular Senescence, and Osteoporosis
Pignolo, R. J., Law, S. F., & Chandra, A. (2021) · JBMR Plus · doi:10.1002/jbm4.10488 · Cited by 201
“However, androgens may indirectly regulate skeletal maintenance by aromatization into estrogen and binding to the estrogen receptor.((202)) In evaluating the role of estrogen deficiency in aging and osteoporosis, independent roles for estrogen function in age-associated bone loss were identified that did not overlap w…”
BackgroundMichael, H., Härkönen, P. L., Väänänen, H. K., & Hentunen, T. A. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050803 · Cited by 200
“Conversion of androgens to E2 by the aromatase enzyme is important for many of the androgen actions on bone.((79)) At the tissue level, E2 suppresses bone turnover and maintains a balance between bone formation and bone resorption.”
BackgroundGonadal steroid–dependent effects on bone turnover and bone mineral density in men
Finkelstein, J. S., Lee, H., Leder, B. Z., Burnett-Bowie, S.-A. M., Goldstein, D. W., Hahn, C. W., Hirsch, S. C., Linker, A., Perros, N., Servais, A. B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84137 · Cited by 198
Hero, M., Norjavaara, E., & Dunkel, L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1392 · Cited by 198
“sults of direct interventional studies (28, 29).”
BackgroundKhosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8397 · Cited by 191
“Based on these data, we estimated that E accounted for two thirds or more of the total effect of sex steroids on bone resorption, with T accounting for at most one third of the effect (12).”
BackgroundMethodResultInfluentialSelf-citationAromatase Activity and Bone Homeostasis in Men
Gennari, L., Nuti, R., & Bilezikian, J. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1717 · Cited by 190
Smith, M. R., Goode, M., Zietman, A. L., McGovern, F. J., Lee, H., & Finkelstein, J. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.174 · Cited by 188
Aromatase: Contributions to Physiology and Disease in Women and Men
Blakemore, J., & Naftolin, F. (2016) · Physiology · doi:10.1152/physiol.00054.2015 · Cited by 185
“Additionally, age-related decline in estrogen can predict bone mass in men similar to that of postmenopausal women (70) via the process of bone resorption (45).”
Brill, K. T., Weltman, A. L., Gentili, A., Patrie, J. T., Fryburg, D. A., Hanks, J. B., Urban, R. J., & Veldhuis, J. D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020098 · Cited by 188
Serum levels of osteoprotegerin increase with age in a healthy adult population.
Kudlacek, S., Schneider, B., Woloszczuk, W., Pietschmann, P., & Willvonseder, R. (2003) · Bone · doi:10.1016/s8756-3282(03)00090-5 · Cited by 187
Endocrinology of the aging male
Araujo, A. B., & Wittert, G. A. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.11.004 · Cited by 182
Heaney, R. P., & Weaver, C. M. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00063-4 · Cited by 182
Khosla, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1740 · Cited by 174
“Previous work had demonstrated that estrogen played an important, and perhaps dominant, role in regulating bone density (19), bone resorption (20, 21), and bone loss (22) in elderly men.”
BackgroundSelf-citationVan Pottelbergh, I., Goemaere, S., & Kaufman, J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021691 · Cited by 174
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
Olszynski, W. P., Shawn Davison, K., Adachi, J. D., Brown, J. P., Cummings, S. R., Hanley, D. A., Harris, S. P., Hodsman, A. B., Kendler, D., McClung, M. R., et al. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90002-1 · Cited by 168
Khosla, S., Melton, L. J., Robb, R. A., Camp, J. J., Atkinson, E. J., Oberg, A. L., Rouleau, P. A., & Riggs, B. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041228 · Cited by 162
“Indeed, whereas previous studies by our group have suggested that estrogen has more potent antiresorptive effects than T,((21)) T does have independent effects on bone resorption.”
BackgroundResultSelf-citationToremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Smith, M. R., Morton, R. A., Barnette, K. G., Sieber, P. R., Malkowicz, S. B., Rodriguez, D., Hancock, M. L., & Steiner, M. S. (2013) · Journal of Urology · doi:10.1016/j.juro.2012.11.016 · Cited by 160
“Estradiol is critical to bone formation and bone resorption in men.(4) The impact of these changes is decreased BMD and increased incidence of clinical fractures.”
Update on Estrogens and the Skeleton
Khosla, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0856 · Cited by 158
Self-citationGennari, L., Masi, L., Merlotti, D., Picariello, L., Falchetti, A., Tanini, A., Mavilia, C., Del Monte, F., Gonnelli, S., Lucani, B., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031342 · Cited by 158
Androgen deprivation therapy for prostate cancer: new concepts and concerns
Smith, M. R. (2007) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32814db88c · Cited by 157
Aromatase inhibitors in men: effects and therapeutic options
de Ronde, W., & de Jong, F. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-93 · Cited by 155
“In experimental settings, selective withdrawal of estradiol in men was associated with an increase in markers of bone resorption [30,81].”
Jehle, S., Hulter, H. N., & Krapf, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3099 · Cited by 155
“The failure of serum bone-specific alkaline phosphatase to increase in parallel with PINP is not understood, but a similar disparity in the performance of these markers was observed during pharmacological simultaneous withdrawal of testosterone and estrogen in normal male subjects (30).”
Deterioration of Trabecular Architecture in Hypogonadal Men
Benito, M., Gomberg, B., Wehrli, F. W., Weening, R. H., Zemel, B., Wright, A. C., Song, H. K., Cucchiara, A., & Snyder, P. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021429 · Cited by 155
“Estradiol appears to contribute more to prevention of bone resorption than testosterone, but both appear to contribute equally to bone formation (55).”
BackgroundIndran, I. R., Liang, R. L. Z., Min, T., & Yong, E. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.015 · Cited by 154
Effects of Aromatase Inhibition in Elderly Men with Low or Borderline-Low Serum Testosterone Levels
Leder, B. Z., Rohrer, J. L., Rubin, S. D., Gallo, J., & Longcope, C. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031467 · Cited by 149
Regulation of adult bone turnover by sex steroids
Frenkel, B., Hong, A., Baniwal, S. K., Coetzee, G. A., Ohlsson, C., Khalid, O. S., & Gabet, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22159 · Cited by 161
“…the role of aromatization in male bone turnover by experimentally treating healthy men with combinations of a GnRH analog (to induce hypogonadism) along with sex steroids and an aromatase inhibitor, thereby selectively restoring AR or ER signaling (Falahati-Nini et al., 2000; Leder et al., 2003).”
BackgroundResultLee, H., McGovern, K., Finkelstein, J. S., & Smith, M. R. (2005) · Cancer · doi:10.1002/cncr.21381 · Cited by 148
“to the regulation of both bone formation and bone resorption in men.(21,22) Serum estradiol levels are”
BackgroundBone health during endocrine therapy for cancer
Rachner, T. D., Coleman, R. E., Hadji, P., & Hofbauer, L. C. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30047-0 · Cited by 164
Burnett-Bowie, S.-A. M., McKay, E. A., Lee, H., & Leder, B. Z. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0739 · Cited by 146
Elbornsson, M., Gotherstrom, G., Bosaeus, I., Bengtsson, B.-A., Johannsson, G., & Svensson, J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1072 · Cited by 144
“Previous studies suggest that estrogen may have a more profound effect on bone remodeling than testosterone ( 41 ), with an effect on both bone resorption and bone formation.”
BackgroundStructural and Metabolic Changes in Bone
Wawrzyniak, A., & Balawender, K. (2022) · Animals · doi:10.3390/ani12151946 · Cited by 194
“Both estrogen and testosterone have effects on bone in both sexes [62,70].”
BackgroundLiu, P. Y., Swerdloff, R. S., & Veldhuis, J. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0807 · Cited by 143
“T T1 E1 Snyder, 1999 (38) 36 108 7 7 7 Amory, 2004 (39) 36 70 7 7 1 Kenny, 2001 (16) 12 67 7 7 Tenover, 1992 (12) 3 13 7 2 Estrogen T2 E1 Doran, 2001 (42) 6 50 7 7 r-hCG T1 E1 Meier, 2004 (44) 3 40 7 DHT T1 E7 Meier, 2004 (44) 3 35 7 7 Selective withdrawal Falahati-Nini, 2000 (43) T2 1 59 2 7 E2 2 1”
BackgroundAndrogens suppress osteoclast formation induced by RANKL and macrophage colony-stimulating factor.
Huber, D. M., Bendixen, A. C., Pathrose, P., Srivastava, S., Dienger, K. M., Shevde, N. K., & Pike, J. W. (2001) · Endocrinology · doi:10.1210/endo.142.9.8402 · Cited by 141
Secondary Osteoporosis: A Review of The Recent Evidence
Painter, S., Kleerekoper, M., & Camacho, P. M. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.436 · Cited by 150
“Indeed, 70% of the gonadal effect on BMD in male subjects may be due to estrogen (7).”
BackgroundAgeing in the musculoskeletal system: Cellular function and dysfunction throughout life
Roberts, S., Colombier, P., Sowman, A., Mennan, C., Rölfing, J. D., Guicheux, J., & Edwards, J. (2016) · Acta Orthopaedica · doi:10.1080/17453674.2016.1244750 · Cited by 183
MECHANISMS IN ENDOCRINOLOGY: Estradiol as a male hormone
Russell, N., & Grossmann, M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-1000 · Cited by 138
Does Body Size Account for Gender Differences in Femur Bone Density and Geometry?
Looker, A. C., Beck, T., & ORWOLL, E. S. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.7.1291 · Cited by 159
“For example, estrogen plays an important role in skeletal homeostasis in both genders (26,27) but the decline in estrogen levels with age is more profound in women because of menopause.”
BackgroundBone Development: Overview of Bone Cells and Signaling
Teti, A. M. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0078-8 · Cited by 147
Wiepjes, C. M., de Jongh, R. T., de Blok, C. J., Vlot, M. C., Lips, P., Twisk, J. W., & den Heijer, M. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3612 · Cited by 136
“However, more recent studies indicated that the effects of hypogonadism on bone in men are mainly due to estrogen instead of testosterone deficiency.((7,8)) In both hypogonadal men and women, treatment with sex hormones increases BMD.”
BackgroundNelson, E. R., Wardell, S. E., & McDonnell, D. P. (2013) · Bone · doi:10.1016/j.bone.2012.11.011 · Cited by 134
“Finally, there is evidence that that 17-β estradiol suppresses both osteoblast and osteocyte apoptosis [37–39].”
BackgroundTestosterone Supplementation in Older Men: A Rational Idea Whose Time Has Not Yet Come
BHASIN, S., & BUCKWALTER, J. G. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02570.x · Cited by 135
Metadata
- Authors
- Falahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Khosla, Sundeep
- Venue
- Journal of Clinical Investigation
- Published
- 2000-12-15
- Volume
- 106
- Issue
- 12
- Pages
- 1553-1560
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC381474
- OpenAlex
- W2144000500
- Cited by
- 757
- References
- 55
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 17 · 2023: 16 · 2022: 24 · 2021: 21 · 2020: 28 · 2019: 28 · 2018: 25 · 2017: 22 · 2016: 34 · 2015: 23 · 2014: 28 · 2013: 31 · 2012: 28
- FWCI
- 29.12
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institutes of Health (AG 04875, RR-00585)
- National Institute on Aging (AG 04875, P01AG004875)
- National Center for Research Resources (RR-00585, M01RR000585)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- testosterone, estrogen, bone resorption, bone formation, bone turnover, older men, osteopenia, osteocalcin, sex steroids, hormone replacement therapy, bone loss
- MeSH terms
- Aged, Aging, Analysis of Variance, Anthropometry, Bone Resorption, Estrogens, Humans, Male, Testosterone, Biomarkers, Bone Density, Osteocalcin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.